Published in Am J Respir Crit Care Med on December 01, 1998
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast | NCT00947453
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 27.17
Airway remodeling in asthma. J Clin Invest (1999) 3.19
Pulmonary function after exposure to the World Trade Center collapse in the New York City Fire Department. Am J Respir Crit Care Med (2006) 2.63
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
Mechanistic links between COPD and lung cancer. Nat Rev Cancer (2013) 2.28
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol (2010) 2.20
Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J (2004) 1.64
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. Thorax (2006) 1.60
A novel tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphism associated with asthma in Australian women. Thorax (2005) 1.55
Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.48
Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol (2002) 1.45
Airway remodelling in children with cystic fibrosis. Thorax (2007) 1.38
MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res (2005) 1.37
Mechanisms of remodeling in asthmatic airways. J Allergy (Cairo) (2012) 1.20
Alternaria-derived serine protease activity drives IL-33-mediated asthma exacerbations. J Allergy Clin Immunol (2014) 1.12
Airway remodelling in asthma: from benchside to clinical practice. Can Respir J (2010) 1.11
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma. Thorax (2005) 1.10
PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir Res (2005) 1.04
Fibrotic response as a distinguishing feature of resistance and susceptibility to pulmonary infection with Mycobacterium tuberculosis in mice. Infect Immun (2007) 1.04
Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency. Respir Res (2011) 0.92
Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.91
Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma. Acta Pharmacol Sin (2010) 0.90
Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases. Clin Exp Immunol (2002) 0.90
Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro. J Investig Med (2010) 0.88
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol (2008) 0.88
Matrix metalloproteinase-3 (stromelysin-1) in acute inflammatory tissue injury. Exp Mol Pathol (2007) 0.88
Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res (2007) 0.85
MMP induced by Gr-1+ cells are crucial for recruitment of Th cells into the airways. Eur J Immunol (2009) 0.84
Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain (2014) 0.81
CXCR4 inhibitor attenuates allergen-induced lung inflammation by down-regulating MMP-9 and ERK1/2. Int J Clin Exp Pathol (2015) 0.80
Variability in proteinase-antiproteinase balance, nutritional status, and quality of life in stable chronic obstructive pulmonary disease due to tobacco and nontobacco etiology. Lung India (2016) 0.79
Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma. ISRN Allergy (2013) 0.79
Budesonide ameliorates lung function of the cigarette smoke-exposed rats through reducing matrix metalloproteinase-1 content. Int J Clin Exp Pathol (2015) 0.78
Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans. J Korean Med Sci (2007) 0.78
The Effects of Uygur Herb Hyssopus officinalis L. on the Process of Airway Remodeling in Asthmatic Mice. Evid Based Complement Alternat Med (2014) 0.78
Targeting lung inflammation: novel therapies for the treatment of COPD. Curr Respir Med Rev (2008) 0.78
Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis. J Biochem (2012) 0.78
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1: expression in the lung of fetal rats with nitrofen-induced diaphragmatic hernia. Pediatr Surg Int (2002) 0.76
Metalloproteinases and Their Tissue Inhibitors in Comparison between Different Chronic Pneumopathies in the Horse. Mediators Inflamm (2015) 0.76
Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. Wien Klin Wochenschr (2014) 0.76
Long-term use of doxycycline can improve chronic asthma and possibly remodeling: the result of a pilot observation. J Asthma Allergy (2012) 0.76
Sinomenine attenuates airway inflammation and remodeling in a mouse model of asthma. Mol Med Rep (2016) 0.76
Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis. Ann Allergy Asthma Immunol (2011) 0.75
Biomarkers in the Management of Difficult Asthma. Curr Top Med Chem (2016) 0.75
Metalloproteinases and their inhibitors are influenced by inhalative glucocorticoid therapy in combination with environmental dust reduction in equine recurrent airway obstruction. BMC Vet Res (2016) 0.75
Risk factors related to persistent airflow obstruction in severe asthma in Chinese Han population. Int J Clin Exp Med (2014) 0.75
The Biology of Eosinophils and Their Role in Asthma. Front Med (Lausanne) (2017) 0.75
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Eosinophilic inflammation in asthma. N Engl J Med (1990) 8.05
A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy (2001) 5.07
A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16
Induction of nitric oxide synthase in asthma. Lancet (1994) 2.93
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J (2010) 2.77
Standards for practical allergen-specific immunotherapy. Allergy (2006) 2.70
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med (2000) 2.36
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy (2010) 2.34
Phylogeny of nitrogenase sequences in Frankia and other nitrogen-fixing microorganisms. J Mol Evol (1989) 2.33
Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy (2007) 2.22
Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy (2011) 2.13
Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med (2000) 2.08
Pro: Immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med (2001) 2.04
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol (1993) 1.91
Sputum induction. Eur Respir J Suppl (2002) 1.88
Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma. Clin Exp Allergy (2004) 1.84
Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med (2008) 1.82
Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J (2002) 1.79
Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy (2007) 1.75
Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75
Upper airway x 1: allergic rhinitis and asthma: united disease through epithelial cells. Thorax (2009) 1.74
GA(2)LEN skin test study I: GA(2)LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy (2009) 1.72
Rhinosinusitis in severe asthma. J Allergy Clin Immunol (2001) 1.72
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71
A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J (2004) 1.70
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med (1998) 1.69
Frequent exacerbators--a distinct phenotype of severe asthma. Clin Exp Allergy (2014) 1.69
Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol (1999) 1.68
Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med (2012) 1.68
Measurement of the internal size of bronchi using high resolution computed tomography (HRCT) Eur Respir J (1994) 1.67
Chloroplast and nuclear gene sequences indicate late Pennsylvanian time for the last common ancestor of extant seed plants. Proc Natl Acad Sci U S A (1994) 1.66
Iatrogenic eosinophilic pleural effusion. Eur Respir Rev (2011) 1.63
Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy (2007) 1.63
Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy (2006) 1.62
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy (2004) 1.61
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy (2005) 1.59
Molecular evolution of angiosperm mitochondrial introns and exons. Proc Natl Acad Sci U S A (1997) 1.56
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med (1997) 1.54
Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy (2013) 1.54
[Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev Mal Respir (2003) 1.54
Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol (1997) 1.53
GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy (2009) 1.51
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50
Update on severe asthma: what we know and what we need. Eur Respir Rev (2009) 1.50
Precision of skin prick and puncture tests with nine methods. J Allergy Clin Immunol (1991) 1.50
Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol (1999) 1.50
Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J (2003) 1.49
Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr (1997) 1.49
Lung compartmentalization of increased TNF releasing ability by mononuclear phagocytes in pulmonary sarcoidosis. Chest (1989) 1.49
Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ (2001) 1.48
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Epidemiology of cypress pollen allergy in Montpellier. J Investig Allergol Clin Immunol (2012) 1.45
Compliance in asthma. Respir Med (1999) 1.44
Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice. J Rheumatol (1997) 1.43
Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy (2010) 1.42
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol (1998) 1.41
[COPD and inflammation: statement from a French expert group: inflammation and remodelling mechanisms]. Rev Mal Respir (2010) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol (1980) 1.40
Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol (1993) 1.39
[Application of the WHO chronic respiratory diseases programme in Sub-Saharian Africa: problems in Senegal]. Rev Mal Respir (2004) 1.39
[Non-communicable chronic diseases, a global public health priority recognized by the United Nations]. Presse Med (2011) 1.39
[Gastric site of epidermoid carcinoma]. Presse Med (1997) 1.39
[Analysis of induced sputum in the management of asthma: a valid technique, a service rendered by community pneumonologists]. Rev Mal Respir (2002) 1.38
[Thrombocytopenia induced by rifampicin not previously sensitized: a case presentation]. Rev Mal Respir (2013) 1.38
Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol (2000) 1.38
Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy (2007) 1.35
Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol (1993) 1.35
The correlation between asthma control and health status: the GOAL study. Eur Respir J (2006) 1.33
Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis (1992) 1.31
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30